(Q40417563)

20 September 2017

title

Adverse reactions to anti-infective agents (English)

1 reference

https://api.crossref.org/works/10.1016/S0011-5029(78)80009-1

2 February 2023

author name string

Rahal JJ Jr

1

1 reference

20 September 2017

J. J. Rahal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A254624

2 February 2023

M. S. Simberkoff

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A254624

2 February 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=254624

2 February 2023

publication date

1 October 1978

1 reference

full work available at URL

20 September 2017

https://api.elsevier.com/content/article/PII:S0011502978800091?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0011-5029(78)80009-1

https://api.elsevier.com/content/article/PII:S0011502978800091?httpAccept=text/plain

2 February 2023

1 reference

https://api.crossref.org/works/10.1016/S0011-5029(78)80009-1

2 February 2023

1 reference

20 September 2017

volume

25

1 reference

20 September 2017

issue

1

1 reference

20 September 2017

page(s)

1-67

1 reference

Interactions Among Antibiotics and Other Drugs

20 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2878%2980009-1

Prediction of penicillin allergy by immunological tests

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2878%2980009-1

Penicillin reactions among patients in venereal disease clinics. A national survey.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2878%2980009-1

Immunologic mechanisms of penicillin allergy. A haptenic model system for the study of allergic diseases of man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2878%2980009-1

Penicillin allergy and the heterogenous immune responses of man to benzylpenicillin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2878%2980009-1

Hypersensitivity reactions to antibacterial drugs in infectious mononucleosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2878%2980009-1

Immunochemical Mechanisms of Penicillin Induced Coombs Positivity and Hemolytic Anemia in Man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2878%2980009-1

Coombs'-test positivity induced by drugs. Mechanisms of immunologic reactions and red cell destruction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2878%2980009-1

Renal failure and interstitial nephritis due to penicillin and methicillin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2878%2980009-1

Antitubular basement-membrane antibodies in methicillin-associated interstitial nephritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2878%2980009-1

Nephropathy Associated with Penicillin and Homologues

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2878%2980009-1

The hemostatic defect produced by carbenicillin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2878%2980009-1

Granulocytopenia associated with carbenicillin. Five episodes in two patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2878%2980009-1

Benzylpenicillin-induced leucopenia. Complication of treatment of bacterial endocarditis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2878%2980009-1

Neutropenia Probably Resulting From Nafcillin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2878%2980009-1

Oxacillin-Induced Hepatic Dysfunction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2878%2980009-1

Reversible oxacillin hepatotoxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2878%2980009-1

7 January 2021

Penicillin neurotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2878%2980009-1

Neurotoxicity during intravenous infusion of penicillin. A review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2878%2980009-1

Blood-Brain and CSF Barriers to Penicillin and Related Organic Acids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2878%2980009-1

Penicillin-induced metabolic alterations in isolated cerebral cortex.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2878%2980009-1

Diarrhea associated with clindamycin and ampicillin therapy: preliminary results of a cooperative study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2878%2980009-1

Gastrointestinal side effects of clindamycin and ampicillin therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2878%2980009-1

Acute enterocolitis. A complication of antibiotic therapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2878%2980009-1

Clinical and laboratory evidence for inactivation of gentamicin by carbenicillin.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2878%2980009-1

Laboratory and Clinical Conditions for Gentamicin Inactivation by Carbenicillin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2878%2980009-1

Inactivation of gentamicin by penicillins in patients with renal failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2878%2980009-1

Interactions between aminoglycoside antibiotics and carbenicillin or ticarcillin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2878%2980009-1

Anaphylaxis to Cephalothin in a Patient Allergic to Penicillin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2878%2980009-1

Prediction of penicillin allergy by immunological tests

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2878%2980009-1

Studies on the epidemiology of adverse drug reactions. IV. The relationship of cephalothin and penicillin allergy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2878%2980009-1

Significant Reduction in the Incidence of Phlebitis with Buffered Versus Unbuffered Cephalothin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2878%2980009-1

Comparative Incidence of Phlebitis Due to Buffered Cephalothin, Cephapirin, and Cefamandole

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2878%2980009-1

Effects of renal failure and dialysis on cefazolin pharmacokinetics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2878%2980009-1

Nephrotoxicity of Cephalosporin Antibiotics in Experimental Animals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2878%2980009-1

Gentamicin Nephrotoxicity: Failure of Three Cephalosporins to Potentiate Injury in Rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2878%2980009-1

Acute renal failure during cephalothin therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2878%2980009-1

Cephalothin-Induced Granulocytopenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2878%2980009-1

Hemolytic Anemia Associated With Cephalothin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2878%2980009-1

Hazards of antibiotic therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2878%2980009-1

Hepatotoxicity of Erythromycin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2878%2980009-1

Chemical structure of erythromycin and hepatotoxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2878%2980009-1

Efficacy of Preoperative Antimicrobial Preparation of the Bowel

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2878%2980009-1

Letter: Effect of benzodiazepines in neonates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2878%2980009-1

Clindamycin-associated colitis. A prospective study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2878%2980009-1

Outbreak of Clindamycin-Associated Colitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2878%2980009-1

Clinical study of gastrointestinal complications associated with clindamycin therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2878%2980009-1

Incidence of diarrhea and colitis associated with clindamycin therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2878%2980009-1

Bile Acids, Diarrhea, and Antibiotics: Data, Speculation, and a Unifying Hypothesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2878%2980009-1

Clindamycin-associated colitis due to a toxin-producing species of Clostridium in hamsters

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2878%2980009-1

Antimicrobial Agent-Induced Diarrhea--A Bacterial Disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2878%2980009-1

Clindamycin and Colitis: A Review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2878%2980009-1

Subtotal colectomy for refractory pseudomembranous enterocolitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2878%2980009-1

Antibiotic blockade of neuromuscular function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2878%2980009-1

Tetracycline hepatotoxicity in the differential diagnosis of postoperative jaundice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2878%2980009-1

Tetracycline poisoning in renal failure.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2878%2980009-1

Methacycline and Demeclocycline in Relation to Sunlight

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2878%2980009-1

Side effects of minocycline: a double-blind study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2878%2980009-1

Benign intracranial hypertension after antibiotic therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2878%2980009-1

Effect of tetracycline on the virulence of Y and M forms of Candida albicans in experimentally induced infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2878%2980009-1

Mechanisms of Action of Chloramphenicol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2878%2980009-1

Chloramphenicol-induced hematopoietic depression: a controlled comparison with tetracycline

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2878%2980009-1

Statewide Study of Chloramphenicol Therapy and Fatal Aplastic Anemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2878%2980009-1

Evaluation of chloramphenicol acid succinate therapy of induced typhoid fever and rocky mountain spotted fever

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2878%2980009-1

Chloramphenicol-associated encephalopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2878%2980009-1

Visual disturbances in cystic fibrosis following chloramphenicol administration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2878%2980009-1

CHLORAMPHENICOL TOXICITY IN LIVER AND RENAL DISEASE

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2878%2980009-1

Persistence of antibiotics in blood of patients with acute renal failure. II. Chloramphenicol and its metabolic products in the blood of patients with severe renal disease or hepatic cirrhosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2878%2980009-1

Comparative ototoxicity of amikacin and gentamicin in cats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2878%2980009-1

Controlled Comparison of Amikacin and Gentamicin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2878%2980009-1

Comparison of Amikacin and Tobramycin in the Treatment of Infection in Patients with Cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2878%2980009-1

Comparative clinical study of tobramycin and gentamicin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2878%2980009-1

Comparative clinical studies of ototoxicity and nephrotoxicity of amikacin and gentamicin.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2878%2980009-1

7 January 2021

Ototoxicity of amikacin

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2878%2980009-1

In vitro uptake of gentamicin by rat renal cortical tissue

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2878%2980009-1

Gentamicin serum concentrations: pharmacokinetic predictions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2878%2980009-1

Gentamicin blood levels: a guide to nephrotoxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2878%2980009-1

Prospective Comparative Study of Variable Dosage and Variable Frequency Regimens for Administration of Gentamicin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2878%2980009-1

Deafness Complicating Antibiotic Therapy of Hepatic Encephalopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2878%2980009-1

Neomycin-induced steatorrhea. A preliminary report on the in vivo hydrolysis of a long-chain unsaturated fat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2878%2980009-1

Aminoglycoside Therapy of Gram-Negative Bacillary Meningitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2878%2980009-1

Letter: Possible hepatitis after intradermal allergy skin testing.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2878%2980009-1

Further Observations on the Diagnosis, Cause, and Treatment of Endophthalmitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2878%2980009-1

Drugs Five Years Later: Spectinomycin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2878%2980009-1

Cross-sensitivity of common aminoglycoside antibiotics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2878%2980009-1

Adverse effects of sodium colistimethate. Manifestations and specific reaction rates during 317 courses of therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2878%2980009-1

Acute Renal Failure Associated With Sodium Colistimethate Treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2878%2980009-1

Colistimethate toxicity. Report of a fatal case in a previously healthy child

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2878%2980009-1

Reversible respiratory paralysis associated with polymyxin therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2878%2980009-1

Mechanism of Colistin-Induced Neuromuscular Depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2878%2980009-1

Trimethoprim-Sulfamethoxazole Treatment ofPneumocystis cariniiPneumonia in Adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2878%2980009-1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2878%2980009-1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2878%2980009-1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2878%2980009-1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2878%2980009-1

THE TREATMENT OF TOXOPLASMA UVEITIS

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2878%2980009-1

Supplemental folates in the therapy of Plasmodium falciparum malaria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2878%2980009-1

Hemolytic Effect of Sulfonamides in Patients with Erythrocytes Deficient in Glucose-6-Phosphate Dehydrogenase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2878%2980009-1

An evaluation of sulfonamide mixtures and various adjuvants for control of sulfonamide crystalluria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2878%2980009-1

Long-term therapy for chronic bacteriuria in men. U.S. Public Health Service cooperative study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2878%2980009-1

Nitrofurantoin pulmonary complications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2878%2980009-1

Nitrofurantoin polyneuropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2878%2980009-1

Bullous photoreaction to nalidixic acid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2878%2980009-1

Childhood Complications of Nalidixic Acid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2878%2980009-1

Intracranial hypertension in a child during treatment with nalidixic acid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2878%2980009-1

Oxolinic acid, a new chemotherapeutic agent in the treatment of urinary tract infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2878%2980009-1

Emergence of resistant organisms as a function of dose in oxolinic acid therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2878%2980009-1

Isoniazid liver injury: clinical spectrum, pathology, and probable pathogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2878%2980009-1

Isoniazid: a review with emphasis on adverse effects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2878%2980009-1

Isoniazid-lnduced Convulsions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2878%2980009-1

Hemolytic anemia with positive Coombs' test. Association with isoniazid therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2878%2980009-1

Isoniazid-induced acne and pellagra. Occurrence in slow inactivators of isoniazid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2878%2980009-1

Adverse reactions to rifampicin in antituberculosis regimens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2878%2980009-1

Effect of Rifampicin and Isoniazid on Liver Function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2878%2980009-1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2878%2980009-1

Interaction of rifampin and warfarin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2878%2980009-1

Rifampin-Induced Methadone Withdrawal

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2878%2980009-1

Adverse reactions to daily and intermittent rifampicin regimens for pulmonary tuberculosis in Hong Kong

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2878%2980009-1

Potentially Serious Side Effects of High-dose Twice-weekly Rifampicin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2878%2980009-1

Sensitivity to rifampicin: incidence, mechanism, and prevention.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2878%2980009-1

Molecular basis for the selective toxicity of amphotericin B for yeast and filipin for animal cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2878%2980009-1

Nephrotoxicity of amphotericin B, with emphasis on changes in tubular function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2878%2980009-1

Renal Tubular Acidosis Due to Amphotericin B Nephrotoxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2878%2980009-1

NEPHROTOXICITY OF AMPHOTERICIN B; EARLY AND LATE EFFECTS IN 81 PATIENTS

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2878%2980009-1

Amphotericin B therapy in an anephric patient

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2878%2980009-1

AMPHOTERICIN B TOXICITY; ANEMIA

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2878%2980009-1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2878%2980009-1

5-fluorocytosine: an oral antifungal compound. A report on clinical and laboratory experience

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2878%2980009-1

Amantadine effect on peripheral airways abnormalities in influenza. A study in 15 students with natural influenza A infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2878%2980009-1

Adenine arabinoside therapy of biopsy-proved herpes simplex encephalitis. National Institute of Allergy and Infectious Diseases collaborative antiviral study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2878%2980009-1

Adenine Arabinoside for Therapy of Herpes Zoster in Immunosuppressed Patients: Preliminary Results of a Collaborative Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2878%2980009-1

Toxicity of Adenine Arabinoside in Humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2878%2980009-1

Microbiologic Assays and Neurological Toxicity during Use of Adenine Arabinoside in Humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2878%2980009-1

Adenine arabinoside therapy of herpes zoster in the immunosuppressed. NIAID collaborative antiviral study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2878%2980009-1

Metronidazole: view of uses and toxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2878%2980009-1

Severe thrombocytopenic purpura complicating pentamidine therapy for pneumocystis carinii pneumonia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2878%2980009-1

Elevated plasma procaine concentrations after administration of procaine penicillin G.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2878%2980009-1

"Pseudoanaphylactic" Reactions from Inadvertent Infusion of Procaine Penicillin G

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2878%2980009-1

Thrombocytopenia with sodium cephalothin therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2878%2980009-1

Ototoxicity of Tobramycin: A Clinical Overview

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2878%2980009-1

inferred from DOI database lookup

7 January 2021

based on heuristic

Clinical problems with drugs

1

1 reference

https://api.crossref.org/works/10.1016/S0011-5029(78)80009-1

More comments on the ampicillin rash problem

2 February 2023

13

1 reference

https://api.crossref.org/works/10.1016/S0011-5029(78)80009-1

Neutropenia during high dose intravenous oxacillin therapy

2 February 2023

25

1 reference

https://api.crossref.org/works/10.1016/S0011-5029(78)80009-1

Pseudomembranous Colitis Associated With Ampicillin Therapy

2 February 2023

36

1 reference

https://api.crossref.org/works/10.1016/S0011-5029(78)80009-1

Studies on the immune response to penicillin and cephalothin in humans. II. Immunohematologic reactions to cephalothin administration

2 February 2023

45

1 reference

https://api.crossref.org/works/10.1016/S0011-5029(78)80009-1

Use of erythromycin ethyl succinate in allergic children

2 February 2023

67

1 reference

https://api.crossref.org/works/10.1016/S0011-5029(78)80009-1

ANAPHYLACTIC REACTIONS TO TETRACYCLINE

2 February 2023

88

1 reference

https://api.crossref.org/works/10.1016/S0011-5029(78)80009-1

Oxolinic acid therapy of recurrent urinary tract infections

2 February 2023

164

1 reference

https://api.crossref.org/works/10.1016/S0011-5029(78)80009-1

Vancomycin therapy of bacterial endocarditis

2 February 2023

167

1 reference

https://api.crossref.org/works/10.1016/S0011-5029(78)80009-1

Rifampin and cell-mediated immune responses in tuberculosis

2 February 2023

190

1 reference

https://api.crossref.org/works/10.1016/S0011-5029(78)80009-1

Vidarabine therapy for severe herpesvirus infections. An unusual syndrome of chronic varicella and transient immunologic deficiency

2 February 2023

202

1 reference

https://api.crossref.org/works/10.1016/S0011-5029(78)80009-1

Treatment of Pneumocystis carinii pneumonitis with trimethoprim-sulfamethoxazole

2 February 2023

209

1 reference

https://api.crossref.org/works/10.1016/S0011-5029(78)80009-1

2 February 2023

Identifiers

1 reference

20 September 2017

1 reference